Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. (2019)
Attributed to:
Imaging perfusion deficits and thrombolysis safety and efficacy in acute ischaemic stroke. The Third International
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(19)30038-8
PubMed Identifier: 30739745
Publication URI: http://europepmc.org/abstract/MED/30739745
Type: Journal Article/Review
Volume: 393
Parent Publication: Lancet (London, England)
Issue: 10174
ISSN: 0140-6736